Execusource Online is looking for a Regulatory Affairs Manager with a generic pharmaceutical manufacturing company near Philadelphia (US). They would report to the Vice President of Compliance and have 6 direct reports.
Further details here.
List your jobs on leading industrial portal ManufacturingHub.co.za for R175 excl. VAT. For further information please e-mail sales@rival.co.za or contact Marc on 082-561-1585
Thursday, October 30, 2008
Friday, October 24, 2008
Admission open in BII for Autumn 2008 Batch
India (SANEPR.com) October 24, 2008 -- Established in 2002 Bioinformatics Institute of India (BII) is a reputed and globally recognised institution for imparting quality education and training in the emerging disciplines of Bioinformatics, Clinical Trials, Pharma Regulatory affairs, Pharma Quality Assurance and Control, Drug Design and Patenting, IPR and Biotechnology etc.
Working professionals from hundreds of reputed companies and students from elite institutes have participated and benefitted from our programs. BII is proud to have participants from more than 40 countries in these programs
Our Distance Participation Industry programs are our most popular programs. Working professionals from hundreds of reputed companies and students from elite institutes have participated and benefited from these programs. BII is proud to have participants from more than 40 countries in these programs. The programs currently on offer are:
• Industry Program in Bioinformatics
• Industry Program in Pharma Regulatory Affairs
• Industry Program in Clinical Trials, Research and Administration
• Industry program in Pharma Quality Assurance and Quality Control
• Industry program in Drug Design and patenting
• Industry program in Intellectual Property Rights
• Industry Program in Biotechnology
• Introductory Program in Bioinformatics.
Classroom Program offered by BII
BII offers 6 months classroom Advance Program in Bioinformatics & 6 months weekend Advance Program in Clinical Trial, Research and data management.
CAREER PROSPECTS:
•Excellent career opportunities exist for students and professionals who are trained in these areas. Placement support is provided.
How to join:
For a free copy of the prospectus email/write to the
Bioinformatics Institute of India
C-56 A/28, Sector 62
Noida
Tel: 0120-4320801, 802
9810535368, 9818473366
Visit : www.bii.in,
Working professionals from hundreds of reputed companies and students from elite institutes have participated and benefitted from our programs. BII is proud to have participants from more than 40 countries in these programs
Our Distance Participation Industry programs are our most popular programs. Working professionals from hundreds of reputed companies and students from elite institutes have participated and benefited from these programs. BII is proud to have participants from more than 40 countries in these programs. The programs currently on offer are:
• Industry Program in Bioinformatics
• Industry Program in Pharma Regulatory Affairs
• Industry Program in Clinical Trials, Research and Administration
• Industry program in Pharma Quality Assurance and Quality Control
• Industry program in Drug Design and patenting
• Industry program in Intellectual Property Rights
• Industry Program in Biotechnology
• Introductory Program in Bioinformatics.
Classroom Program offered by BII
BII offers 6 months classroom Advance Program in Bioinformatics & 6 months weekend Advance Program in Clinical Trial, Research and data management.
CAREER PROSPECTS:
•Excellent career opportunities exist for students and professionals who are trained in these areas. Placement support is provided.
How to join:
For a free copy of the prospectus email/write to the
Bioinformatics Institute of India
C-56 A/28, Sector 62
Noida
Tel: 0120-4320801, 802
9810535368, 9818473366
Visit : www.bii.in,
Wednesday, October 15, 2008
Refind - Web 3.0 searching
Dear Researchers,
ResearchGATE is proud to announce a major update: We greatly improved our search functionality and called it ReFind. The name symbolizes the importance of an efficient and result-driven search functionality within research in general and within our network in particular.
Most of the search engines on the web are actually – stupid. This sounds harsh, but it is true: Their algorithms provide you with page results based on criteria such as the number of occurrences of search terms and on their overall audience. But do you really care about this as a researcher with special interests? Probably, no. Research topics are often too complex to be narrowed down into a few words.
ReFind, instead, is one of the first search engines based on semantic, “intelligent” correlations. It enables you to find groups, papers, fellow researchers and everything else within and outside of ResearchGATE without having to read through dozens of irrelevant results. Just type a few sentences into ReFind or simply copy and paste your abstract. Our semantic algorithm will then search the leading databases for similar work, providing you with truly relevant results.
This is the way to Web 3.0!
Please try it out and send us your feedback.
Thanks!
The ResearchGATE Team
ResearchGATE is proud to announce a major update: We greatly improved our search functionality and called it ReFind. The name symbolizes the importance of an efficient and result-driven search functionality within research in general and within our network in particular.
Most of the search engines on the web are actually – stupid. This sounds harsh, but it is true: Their algorithms provide you with page results based on criteria such as the number of occurrences of search terms and on their overall audience. But do you really care about this as a researcher with special interests? Probably, no. Research topics are often too complex to be narrowed down into a few words.
ReFind, instead, is one of the first search engines based on semantic, “intelligent” correlations. It enables you to find groups, papers, fellow researchers and everything else within and outside of ResearchGATE without having to read through dozens of irrelevant results. Just type a few sentences into ReFind or simply copy and paste your abstract. Our semantic algorithm will then search the leading databases for similar work, providing you with truly relevant results.
This is the way to Web 3.0!
Please try it out and send us your feedback.
Thanks!
The ResearchGATE Team
Tuesday, September 30, 2008
Green Revolution to Gene Revolution - Foods from Modern Biotechnology"
Event name:"Green Revolution to Gene Revolution - Foods from Modern Biotechnology"
Start Date:03 October 2008
Time:12h30 - 14h00
Venue: Exhibition Hall, The UCT Graduate School of Business, Breakwater Campus, Duration:2 hours
The UCT Graduate School of Business in association with Deloitte is proud to present: "Green Revolution to Gene Revolution - Foods from Modern Biotechnology" Presented by American academic, Professor Bruce Chassy, a biochemist at the University of Illinois Professor Chassy’s research focuses on the characterisation and development of methods for the genetic manipulation of microorganisms used in food and dairy fermentations. His research experiences with the development of genetically modified microorganisms that are used in foods led him to an interest in food safety and the safety evaluation of "biotech foods." The presentation is designed to give the balanced facts as to "what they are, and what they are not" and "why they are developed and grown". It includes a brief mention of nutritionally-improved/enhanced crops, including some developments that are in the pipeline. The take-home message: "The science and the care that is being taken in applying it"
website:www.gsb.uct.ac.za
Wednesday, September 17, 2008
Chemistry and innovation
For those with a little interest in commercial science / biotechnology investments, you might be interesting in this workshop here.
Tuesday, September 16, 2008
Stem Cells From Patient
Thailand (SANEPR.com) September 16, 2008 -- A collaboration between Bangkok Hospital Medical Center, Theravitae Ltd and the University of Pittsburgh has created a new stem cell therapy treatment option at Bangkok's world-class hospital and medical facility.Patients with heart damage or heart failure can now be treated at Bangkok Heart Hospital (a division of Bangkok Hospital Medical Centre) with stem cells from their own peripheral blood tissue.
Stem cell therapy involves the use of partially differentiated or undifferentiated cells to treat damaged tissue in several areas of the body. Their damaged heart muscle can be repaired without the need for tissue transplants or mechanical insertions. The stem cells used are known as angiogenic precursor cells.
These cells are designated as unipotent, that is, they have the potential only to become one type of mature cell. However, their undeveloped status means that the body can utilize and reproduce them in a way it cannot with mature cells. Cell selection and expansion using this method takes about a week - thousands of times less what it might take to find a suitable donor for heart tissue.Magnetic resonance imaging, a thoracoscopic camera and keyhole surgery are used to administer the stem cell product directly to the damaged area of the heart. The surgery involves a small incision being made in the left side of the chest, and a thoracoscopic camera being inserted into the thoracic cavity.
The cells are injected directly into the cardiac muscle at the point of damage, which is located using an MRI. The technology also has the potential to be able to grow new heart tissue from a person's own stem cells, and Bangkok Hospital is leading the world in research in this area.The new treatment option at Bangkok Heart Hospital means that medical tourists have a less invasive, more natural and scientifically advanced method of treatment for coronary artery disease and heart failure at a world-leading facility.
Bangkok Hospital is accredited by TEMOS (Telemedicine for the Mobile Society), an organization which assures international travelers of the quality and safety standards of hospitals worldwide.
It also involves a patient's home doctor in the treatment and recovery process. For more information, please see http://www.bangkokhospital.com/App/NewsEventsDetail.aspx?newsid=73 and www.bangkokhospital.com
Stem cell therapy involves the use of partially differentiated or undifferentiated cells to treat damaged tissue in several areas of the body. Their damaged heart muscle can be repaired without the need for tissue transplants or mechanical insertions. The stem cells used are known as angiogenic precursor cells.
These cells are designated as unipotent, that is, they have the potential only to become one type of mature cell. However, their undeveloped status means that the body can utilize and reproduce them in a way it cannot with mature cells. Cell selection and expansion using this method takes about a week - thousands of times less what it might take to find a suitable donor for heart tissue.Magnetic resonance imaging, a thoracoscopic camera and keyhole surgery are used to administer the stem cell product directly to the damaged area of the heart. The surgery involves a small incision being made in the left side of the chest, and a thoracoscopic camera being inserted into the thoracic cavity.
The cells are injected directly into the cardiac muscle at the point of damage, which is located using an MRI. The technology also has the potential to be able to grow new heart tissue from a person's own stem cells, and Bangkok Hospital is leading the world in research in this area.The new treatment option at Bangkok Heart Hospital means that medical tourists have a less invasive, more natural and scientifically advanced method of treatment for coronary artery disease and heart failure at a world-leading facility.
Bangkok Hospital is accredited by TEMOS (Telemedicine for the Mobile Society), an organization which assures international travelers of the quality and safety standards of hospitals worldwide.
It also involves a patient's home doctor in the treatment and recovery process. For more information, please see http://www.bangkokhospital.com/App/NewsEventsDetail.aspx?newsid=73 and www.bangkokhospital.com
Monday, September 15, 2008
SA listed pharmaceuticals assessed
South African based industrial publishing house and research company, ManufacturingHub.co.za will be releasing an industrial report of listed pharmaceutical companies on the JSE for the third quarter of 2008.
Read full details of the report here.
Read full details of the report here.
Subscribe to:
Posts (Atom)
Posts
